previous compound ID: 1705 next compound
InChIKey: PJDFLNIOAUIZSL-UHFFFAOYSA-N
SMILES: C=CC(CCC(=O)O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "J Goepp" "E Matthes" "R Robert" "D Rotin" "B Kus" "GW Carlile" "JW Hanrahan" "SD Macknight" "J Liao"

chemical graph of compound 1705





CID is 5665
synonyms found at PubChem are:
vigabatrin, 4-aminohex-5-enoic acid, Sabril, 60643-86-9, Vigabatrine, gamma-Vinyl GABA, 4-Amino-5-hexenoic acid, 68506-86-5, Vigabatrina, Vigabatrinum, gamma-Vinyl-GABA, Vigabatrine [French], Vigabatrinum [Latin], Vigabatrina [Spanish], 5-Hexenoic acid, 4-amino-, Sabrilex, gamma-Vinyl-gamma-Aminobutyric Acid, MDL-71754, gamma Vinyl GABA, Sabril (TN), 4-Aminohexenoic acid, Vigabatrin [USAN:INN:BAN], GVG, MDL 71754, RMI 71754, RMI-71754, Vigabatrin [USAN:BAN:INN], CPP-109, Hexenoic acid, 4-amino, 4-Amino-hex-5-enoic acid, (+/-)-gamma-Vinyl-GABA, CHEMBL89598, Vigabatrin (JAN/USAN/INN), CHEBI:63638, PJDFLNIOAUIZSL-UHFFFAOYSA-N, (R,S)-4-Amino-5-hexenoic acid, VINYL GAMMA-AMINOBUTYRIC ACID, RMI-71890, vigabatrin HCl, MDL 71,754, NCGC00016087-06, V 8261, M071754, SR-01000075653, (+-)-gamma-Vinyl GABA, (1)-4-Aminohex-5-enoic acid, CPP 109, Sabrilex (TN), gamma Vinyl gamma Aminobutyric Acid, Prestwick_837, EINECS 270-929-6, Acid, gamma-Vinyl-gamma-Aminobutyric, CAS-60643-86-9, (+/-)-Vigabatrin, .gamma.-vinyl GABA, .gamma.-Vinyl-GABA, Spectrum_000368, SpecPlus_000664, Vigabatrin Aventis Brand, Vigabatrin Hoechst Brand, (y)-gamma-Vinyl GABA, AC1L1KUZ, Prestwick0_000501, Prestwick1_000501, Prestwick2_000501, Prestwick3_000501, Spectrum3_001825, (?)-gamma-Vinyl GABA, Biomol-NT_000247, D0R3QY, Vigabatrin Yamanouchi Brand, Aventis Brand of Vigabatrin, Hoechst Brand of Vigabatrin, DSSTox_CID_21153, DSSTox_RID_79637, DSSTox_GSID_41153, Lopac0_001277, SCHEMBL26714, (+/-)-gamma-Vinyl GABA, BSPBio_000421, BSPBio_003469, KBioSS_000848, (A+/-)-gamma-Vinyl GABA, DivK1c_006760, SPECTRUM1502036, V8261_SIGMA, (+/-)-?-Vinyl GABA, SPBio_002342, Yamanouchi Brand of Vigabatrin, (+/-)-4-Aminohexenoic acid, BPBio1_000465, BPBio1_000925, GTPL4821, DTXSID4041153, Vinyl .gamma.-aminobutyric Acid, CTK7D4255, KBio1_001704, KBio2_000848, KBio2_003416, KBio2_005984, KBio3_002973, AOB6800, MolPort-003-666-796, HMS1569F03, HMS2094M21, HMS2096F03, HMS3263P16, (plusmn)-4-aminohex-5-enoic acid, (+/-)-4-Amino-5-hexenoic acid, Tox21_110301, Tox21_501277, BDBM50118886, MFCD00274577, AKOS015854596, ACN-036276, CCG-205350, CS-0791, DB01080, LP01277, (?)-4-AMINOHEX-5-ENOIC ACID, .gamma.-Vinyl-.gamma.-aminobutyric acid, NCGC00016087-03, NCGC00016087-04, NCGC00016087-05, NCGC00016087-07, NCGC00016087-08, NCGC00016087-09, NCGC00016087-11, NCGC00024802-02, NCGC00024802-03, NCGC00024802-04, NCGC00024802-05, NCGC00024802-06, NCGC00261962-01, AN-39442, AS-11778, HY-15399, KB-81443, LS-75569, SC-20397, (inverted question mark)-gamma-Vinyl GABA, SBI-0051243.P003, ( inverted question mark)-gamma-Vinyl GABA, AB0010729, KB-240224, AB00053309, EU-0101277, FT-0700968, gamma-Vinyl GABA; 4-Amino-5-hexenoic acid, C07500, D00535, W-5102, AB00053309_04, Q-201924, SR-01000075653-1, SR-01000075653-4, SR-01000075653-6, ( inverted exclamation markA)-4-aminohex-5-enoic acid, BRD-A07893380-001-01-6, Z2235791448, Vigabatrin, European Pharmacopoeia (EP) Reference Standard, Vigabatrin, United States Pharmacopeia (USP) Reference Standard